Showing results (191-200 of 301) with videos related to

Sort By:
Pageof 31
The Journal of Clinical Investigation|June 5, 2018
ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5DKazumasa Komura, Yuki Yoshikawa, Teppei Shimamura, et al.
Targeted Oncology|April 22, 2026
First-Line Therapy for Advanced Renal Cell Carcinoma: Score-Matched Analysis of Dual Combination Immunotherapy versus Combination of Tyrosine Kinase Inhibitors and Immunotherapy in the TOURS Multicenter StudyHiromitsu Watanabe, Keita Nakane, Takuhisa Nukaya, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 28, 2025
Impact of Estimated Glomerular Filtration Rate and Serum C-Reactive Protein Level to Overall Survival After Second-Line Targeted Therapy Following Immuno-Oncology Combination Therapy for Advanced Renal Cell CarcinomaKeita Nakane, Hiromitsu Watanabe, Taku Naiki, et al.
IJU Case Reports|September 5, 2025
Robot-Assisted Partial Nephrectomy for Multiple Synchronous Renal Tumors in Unilateral Kidney Using Hinotori Surgical System: A Case ReportKento Ozawa, Hiromitsu Watanabe, Kyohei Watanabe, et al.
The Journal of Gene Medicine|October 30, 2004
An efficient gene transfer method mediated by ultrasound and microbubbles into the kidneyHiromi Koike, Naruya Tomita, Haruhito Azuma, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 20, 2017
Recall features and allorecognition in innate immunityHirofumi Uehara, Koichiro Minami, Markus Quante, et al.
Transplantation|October 15, 2003
Significant prolongation of animal survival by combined therapy of FR167653 and cyclosporine A in rat renal allograftsHaruhito Azuma, Takashi Wada, Rieko Gotoh, et al.
Plos One|April 7, 2017
Assessment of the ability of CT urography with low-dose multi-phasic excretory phases for opacification of the urinary systemHiroshi Juri, Takahiro Tsuboyama, Mitsuhiro Koyama, et al.
Molecular Cancer|November 19, 2023
The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder CancerKazumasa Komura, Kensuke Hirosuna, Satoshi Tokushige, et al.
Cancers|November 26, 2022
Serum C-reactive Protein Level Predicts Overall Survival for Clear Cell and Non-Clear Cell Renal Cell Carcinoma Treated with Ipilimumab plus NivolumabYusuke Yano, Takaya Ohno, Kazumasa Komura, et al.
Pageof 31